Skip to main content

Table 2 Summary of different types of statin treatments in type 2 diabetes patients (T2D) and patients without diabetes (No T2D)

From: Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events

 

All

No T2D (n = 129)

T2D (n = 71)

Simvastatin, n (high/intermediate/low dose)

137 (76/52/9)

88 (44/37/7)

49 (32/15/2)

Pravastatin, n (high/intermediate/low dose)

7 (4/3/0)

5 (2/3/0)

2 (2/0/0)

Atorvastatin, n (high/intermediate/low dose)

16 (2/4/10)

7 (1/3/3)

9 (1/1/7)

Rosuvastatin, n (high/intermediate/low dose)

4 (1/1/2)

0 (0/0/0)

4 (1/1/2)

  1. Statin treatments were divided into low, intermediate or high dose accordingly: Simvastatin (10 mg, 20–30 mg, 40 mg), Pravastatin (10 mg, 20 mg, 40 mg), Atorvastatin (10–30 mg, 40 mg, 80 mg) and Rosuvastatin (5–10 mg,  > 10–20 mg,  > 20–40 mg)